Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-related Functional Decline (ICOPE Trial.Fr)

Recruiting now · Not applicable

Conditions studied: Ageing

In brief

The World Health Organization (WHO) has designed an integrated care program (ICOPE) aimed at maintaining the functions of elderly people to preserve their autonomy. It includes four steps (Screening, Comprehensive Assessment, Personalized Prevention and Care Plan, Follow-up). The screening tool assesses a person's intrinsic capacity in six key functional domains (mobility, cognition, nutrition, vision, hearing, psychological well-being). This screening can be conducted by a professional or through self-assessment using the digital application (ICOPE Monitor). If a deficit is detected, an alert is issued, and if confirmed by a healthcare professional trained in ICOPE, a comprehensive assessment of the impaired function and a personalized prevention and care plan is proposed by the physician. A trained nurse assists the person in implementing this plan in collaboration with the primary care physician and local professionals. When multiple functions are impaired, it is recommended to conduct a thorough evaluation of all six functions to implement an integrated approach. The clinical effectiveness of the program in preventing functional decline has not yet been established in a sufficiently long trial. The investigators propose to evaluate the effect and cost of the ICOPE program in France through a controlled trial. Our hypothesis is that, in the current primary care context, the comprehensive implementation of the program (combining regular screening, comprehensive assessment, prevention and care plan, and follow-up) is necessary to more effectively prevent age-related functional decline compared to the usual care provided by the primary care physician.

Key facts

Study ID

NCT06676839

Run by

University Hospital, Toulouse

People needed

1000

Starts

2024-10-14

Expected to finish

2031-10-31

Last updated by the study team

2026-03-23

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants aged 65 years and older.
• Participants living independently at home (ADL = 6, except for an occasional urinary abnormality which will be accepted).
• Participants showing functional decline in at least 2 of the 6 functional domains of ICOPE (mobility, cognition, nutrition, vision, hearing, and psychological well-being) identified using the ICOPE screening tool.
• Participants affiliated with a social protection system.

You may not qualify if…

• Participants who has already benefited from the ICOPE program or who has completed more than one isolated step 1
• Participants living in a dependent elderly care facility.
• Participants with a disability preventing them from reaching the trial examination center without assistance (such as dementia or significant mobility impairment).
• Participants with hearing, visual, or speech impairments preventing them from understanding instructions or communicating with study staff.
• Participants with a life-threatening illness with a prognosis of less than 5 years.
• Participants unable to provide informed written consent.
• Participants under legal protection, guardianship, or trusteeship.
• Participants participating in another interventional research study.
• Participants in a relationship with a person participating in the study.

Where it is running

• CHIC — Castres, France, France (enrolling)
• Perpignan Hospital — Perpignan, France, France (enrolling)
• Bigorre Hospital — Tarbes, France, France (enrolling)
• CHU Toulouse — Toulouse, France, France (enrolling)
• Angers University hospital — Angers, France (enrolling)
• Limoges university hospital — Limoges, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.